Cite
APA Citation
Robak, T., Hellmann, A., Kloczko, J., Loscertales, J., Lech‐Maranda, E., Pagel, J. M., Mato, A., Byrd, J. C., Awan, F. T., Hebart, H., Garcia‐Marco, J. A., Hill, B. T., Hallek, M., Eisenfeld, A. J., Stromatt, S. C., & Jaeger, U. (2017). randomized phase 2 study of otlertuzumab and bendamustine versus bendamustine in patients with relapsed chronic lymphocytic leukaemia. British journal of haematology, 176, 618–628. http://access.bl.uk/ark:/81055/vdc_100041767516.0x000039